These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 10463408)

  • 1. Survival of glaucoma patients.
    Egge K; Zahl PH
    Acta Ophthalmol Scand; 1999 Aug; 77(4):397-401. PubMed ID: 10463408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of survival of exfoliative glaucoma patients and primary open-angle glaucoma patients: impact of acetazolamide use.
    Ritland JS; Egge K; Lydersen S; Juul R; Semb SO
    Acta Ophthalmol Scand; 2004 Aug; 82(4):397-400. PubMed ID: 15291931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exfoliative glaucoma and primary open-angle glaucoma: associations with death causes and comorbidity.
    Ritland JS; Egge K; Lydersen S; Juul R; Semb SO
    Acta Ophthalmol Scand; 2004 Aug; 82(4):401-4. PubMed ID: 15291932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GLAUCOMA TREATED WITH DARANIDE A CLINICAL TRIAL.
    Luntz MH
    Br J Ophthalmol; 1961 Feb; 45(2):125-9. PubMed ID: 18170651
    [No Abstract]   [Full Text] [Related]  

  • 5. [Salicylism and glaucoma: reciprocal augmentation of the toxicity of acetazolamide and acetylsalicylic acid].
    Hazouard E; Grimbert M; Jonville-Berra AP; De Toffol MC; Legras A
    J Fr Ophtalmol; 1999 Feb; 22(1):73-5. PubMed ID: 10221197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Impact of prostaglandin-F(2alpha)-analogues and carbonic anhydrase inhibitors on central corneal thickness -- a cross-sectional study on 403 eyes].
    Viestenz A; Martus P; Schlötzer-Schrehardt U; Langenbucher A; Mardin CY
    Klin Monbl Augenheilkd; 2004 Sep; 221(9):753-6. PubMed ID: 15459842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent life-threatening acidosis induced by acetazolamide in a patient with diabetic type IV renal tubular acidosis.
    Elinav E; Ackerman Z; Gottehrer NP; Heyman SN
    Ann Emerg Med; 2002 Aug; 40(2):259-60. PubMed ID: 12140510
    [No Abstract]   [Full Text] [Related]  

  • 8. Open-angle glaucoma and cardiovascular mortality: the Blue Mountains Eye Study.
    Lee AJ; Wang JJ; Kifley A; Mitchell P
    Ophthalmology; 2006 Jul; 113(7):1069-76. PubMed ID: 16815396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Additive ocular hypotensive effect of latanoprost and acetazolamide. A short-term study in patients with elevated intraocular pressure.
    Rulo AH; Greve EL; Hoyng PF
    Ophthalmology; 1997 Sep; 104(9):1503-7. PubMed ID: 9307648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraocular pressure effects of carbonic anhydrase inhibitors in primary open-angle glaucoma.
    Lichter PR; Musch DC; Medzihradsky F; Standardi CL
    Am J Ophthalmol; 1989 Jan; 107(1):11-7. PubMed ID: 2643331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerability and efficacy of dorzolamide versus acetazolamide added to timolol.
    Stewart WC; Halper LK; Johnson-Pratt L; Polis A; Hartenbaum D
    J Ocul Pharmacol Ther; 2002 Jun; 18(3):211-20. PubMed ID: 12099542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic Effect of Oral Acetazolamide against Intraocular Pressure Elevation after Cataract Surgery in Eyes with Glaucoma.
    Hayashi K; Yoshida M; Manabe SI; Yoshimura K
    Ophthalmology; 2017 May; 124(5):701-708. PubMed ID: 28110949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the efficacy and tolerability of dorzolamide and acetazolamide as adjunctive therapy to timolol. Oral to Topical CAI Study Group.
    Hutzelmann JE; Polis AB; Michael AJ; Adamsons IA
    Acta Ophthalmol Scand; 1998 Dec; 76(6):717-22. PubMed ID: 9881560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pustular psoriasis precipitated by acetazolamide.
    Kuroda K; Kojima T; Tanabe E; Fujita M; Shinkai H
    J Dermatol; 1995 Oct; 22(10):784-7. PubMed ID: 8586762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbonic anhydrase inhibition in glaucoma: hazard or benefit for the chronic lunger?
    Block ER; Rostand RA
    Surv Ophthalmol; 1978; 23(3):169-72. PubMed ID: 734612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acetazolamide-related life-threatening hypophosphatemia in a glaucoma patient.
    Hu CY; Lee BJ; Cheng HF; Wang CY
    J Glaucoma; 2015; 24(4):e31-3. PubMed ID: 25333610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of oral acetazolamide on weight gain in children.
    Sharan S; Dupuis A; Hébert D; Levin AV
    Can J Ophthalmol; 2010 Feb; 45(1):41-5. PubMed ID: 20130709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute bilateral angle-closure glaucoma and choroidal effusion associated with acetazolamide administration after cataract surgery.
    Mancino R; Varesi C; Cerulli A; Aiello F; Nucci C
    J Cataract Refract Surg; 2011 Feb; 37(2):415-7. PubMed ID: 21241929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reducing side effects of carbonic anhydrase inhibitors.
    Lichter PR
    Ophthalmology; 1981 Mar; 88(3):266-9. PubMed ID: 7231916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of systemic acetazolamide and topical dorzolamide in reducing intraocular pressure and aqueous humor formation.
    Rosenberg LF; Krupin T; Tang LQ; Hong PH; Ruderman JM
    Ophthalmology; 1998 Jan; 105(1):88-92; discussion 92-3. PubMed ID: 9442783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.